| Value | ₹859.7 Cr |
|---|
BSE filing, NSE: DCXINDIA. Summary written from the filing by ALFA Finder's alert engine.
DCX Systems Ltd: key numbers
- Share price
- ₹132.66
- Market cap
- ₹1,478 Cr
- Revenue (annual)
- ₹743.3 Cr
- Net profit (annual)
- ₹-7.71 Cr
- P/E (TTM)
- -72.3×Sector 51.5×
- Promoter holding
- 52.16%+0.00% QoQ
- FII holding
- 1.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DCX Systems Ltd
All →DCX Systems Other Announcement
DCX Systems Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI regulatory requirements.
DCX Systems Annual General Meeting
DCX Systems held its 15th Annual General Meeting on September 28, 2026. The agenda included adopting financial statements and re-appointing a director.
DCX Systems Annual Report
DCX Systems Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its 15th Annual General Meeting.
DCX Systems Annual General Meeting
DCX Systems Limited has scheduled its 15th Annual General Meeting for Monday, September 28, 2026, to be conducted via Video Conferencing.
DCX Systems Bags ₹5.28 Cr Order
DCX Systems Ltd secured a Rs. 5.28 Crore contract from domestic entities to manufacture and supply cable and wire harness assemblies over 24 months.
- Value
- ₹5.28 Cr
- Execution
- 24 Months
DCX Systems Bags ₹13 Cr Order
DCX Systems secured an order worth ₹13 Crore from international entities for the supply of cable and PCB assemblies. The contract will be executed over 24 months.
- Value
- ₹13.00 Cr
- Execution
- 24 Months
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.